We are live on
!
Find out more
CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.53B
1-Year Est. Return
48.83%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
-$97.4M
(-4.6%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-5.55%
Top 10 Holdings %
Top 10 Hldgs %
11.33%
Holding
698
New
210
Increased
118
Reduced
125
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$18.9M |
| 2 |
Baxter International
BAX
|
+$18.2M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$17M |
| 4 |
T-Mobile US
TMUS
|
+$16.5M |
| 5 |
Merck
MRK
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$22.2M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$21M |
| 3 |
Paycom
PAYC
|
+$19.5M |
| 4 |
Canadian Natural Resources
CNQ
|
+$14.1M |
| 5 |
Gilead Sciences
GILD
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.02% |
| 2 | Technology | 17.87% |
| 3 | Consumer Discretionary | 12.08% |
| 4 | Financials | 10% |
| 5 | Energy | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Fulgent Genetics
FLGT
$470M
| $1.17M | 0.06% |
+13,000
| New | +$1.18M |
|
|
LTHM
377
DELISTED
Livent Corporation
LTHM
| $1.16M | 0.06% |
+50,000
| New | +$1.12M |
|
378
CALL
Xenon Pharmaceuticals
XENE
$6.06B
| $1.15M | 0.06% |
+75,000
| New | +$1.3M |
|
379
Torrid Holdings
CURV
$254M
| $1.12M | 0.06% |
+72,875
| New | +$1.73M |
|
|
EMKR
380
DELISTED
Emcore Corp
EMKR
| $1.12M | 0.05% |
15,000
-25,000
| -63% | -$2M |
|
|
ACCD
381
DELISTED
Accolade Inc
ACCD
| $1.12M | 0.05% |
+26,589
| New | +$1.25M |
|
382
Edwards Lifesciences
EW
$49.6B
| $1.11M | 0.05% |
9,823
-57,006
| -85% | -$6.51M |
|
|
CCXI
383
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.11M | 0.05% |
+65,000
| New | +$1.01M |
|
384
CONMED
CNMD
$1.39B
| $1.11M | 0.05% |
+8,487
| New | +$1.11M |
|
385
PUT
AngioDynamics
ANGO
$611M
| $1.1M | 0.05% |
+42,500
| New | +$1.14M |
|
386
Signet Jewelers
SIG
$3.61B
| $1.1M | 0.05% |
+13,950
| New | +$1.02M |
|
|
SEE
387
DELISTED
Sealed Air
SEE
| $1.1M | 0.05% |
+20,000
| New | +$1.16M |
|
|
SBNY
388
DELISTED
Signature Bank
SBNY
| $1.08M | 0.05% |
+3,967
| New | +$996K |
|
|
CVE.WS
389
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $1.07M | 0.05% |
180,600
| – | – |
|
390
Crown Holdings
CCK
$12.8B
| $1.06M | 0.05% |
10,517
+6,017
| +134% | +$631K |
|
391
Albemarle
ALB
$13.9B
| $1.05M | 0.05% |
4,800
+2,400
| +100% | +$513K |
|
|
PSTH
392
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $1.03M | 0.05% |
52,500
-20,500
| -28% | -$416K |
|
|
393
Elevance Health
ELV
$81.5B
| $1.02M | 0.05% |
2,748
-58,349
| -96% | -$22.2M |
|
|
STFC
394
DELISTED
State Auto Financial Corp
STFC
| $1.02M | 0.05% |
+20,000
| New | +$947K |
|
|
TRIL
395
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.02M | 0.05% |
+58,000
| New | +$678K |
|
396
CALL
Senseonics Holdings Inc
SENS
$263M
| $1.02M | 0.05% |
+15,000
| New | +$1.02M |
|
397
PBF Energy
PBF
$8.57B
| $1M | 0.05% |
+77,311
| New | +$802K |
|
398
First Advantage
FA
$3.4B
| $995K | 0.05% |
52,230
-12,615
| -19% | -$265K |
|
|
HTPA
399
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $992K | 0.05% |
99,997
| – | – |
|
400
CALL
Standard BioTools
LAB
$340M
| $989K | 0.05% |
+150,000
| New | +$987K |
|
Similar funds
MCP
ICM
FI
FBB
SG
CET
HR
CCP
Cinctive Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cinctive Capital Management held 698 positions worth $2.04B, down 4.6% from $2.14B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cinctive Capital Management withdrew a net $113M in Q3 2021, closing 177 positions and reducing 125 holdings. Its most notable exit was Canadian Natural Resources, an estimated $14.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cinctive Capital Management opened a new position in Thermo Fisher Scientific worth $19.7M.
- Cinctive Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 34,421 shares worth $19.7M.
- Cinctive Capital Management added most to Eli Lilly in Q3 2021, an estimated $11.2M increase.
- Cinctive Capital Management's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $22.2M.
- Cinctive Capital Management fully exited Canadian Natural Resources in Q3 2021, selling an estimated $14.1M.
- Cinctive Capital Management's ten largest holdings make up 11% of its $2.04B portfolio in Q3 2021.
- Cinctive Capital Management opened 210 new positions and closed 177 in Q3 2021.
- Cinctive Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.04B.
Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.